Q4 2016 Holdings
Filed 2017-02-21 | 40 holdings | $30.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Axogen Inc(AXGN) | COM | 05463X106 | $17.7M | 1,970,000 | 58.0% |
| Agios Pharmaceuticals(AGIO) | COM | 00847X104 | $5.4M | 130,000 | 17.8% |
| Codexis Inc(CDXS) | COM | 192005106 | $5.4M | 1,170,000 | 17.6% |
| Cytomx Therapeutics Inc(CTMX) | COM | 23284F105 | $1.9M | 170,000 | 6.1% |
| Blueprint Medicines(2L9) | COM | 09627Y109 | $24.7K | 880,000 | 0.1% |
| Ariad Pharmaceuticals Inc | COM | 04033A100 | $12.4K | 1,000,000 | 0.0% |
| Aevi Genomic Medicine Inc(GNMXEUR) | COM | 00835P105 | $7.8K | 1,500,000 | 0.0% |
| Fibrogen Inc(FGENEUR) | COM | 31572Q808 | $7.1K | 330,000 | 0.0% |
| Foamix Pharmaceuticals LTD | SHS | M46135105 | $5.5K | 495,000 | 0.0% |
| Chimerix Inc(CMRXEUR) | COM | 16934W106 | $5.4K | 1,170,000 | 0.0% |
| Aquinox Pharmaceuticals Inc | COM | 03842B101 | $5.1K | 310,000 | 0.0% |
| Theravance Biopharma Inc(TBPH) | ORD SHS | G8807B106 | $5.0K | 158,200 | 0.0% |
| Momenta Pharmaceuticals Inc(MNTA) | COM | 60877T100 | $5.0K | 330,000 | 0.0% |
| Adamas Pharmaceuticals Inc(ADMSEUR) | COM | 00548A106 | $4.8K | 285,000 | 0.0% |
| Cara Therapeutics(CARAEUR) | COM | 140755109 | $4.4K | 475,000 | 0.0% |
| Prothena Corp PLC(PRTA) | SHS | G72800108 | $4.1K | 82,500 | 0.0% |
| Loxo Oncology | COM | 548862101 | $4.0K | 125,000 | 0.0% |
| Eagle Pharmaceuticals Inc(EGRX) | COM | 269796108 | $4.0K | 50,000 | 0.0% |
| Edge Therapeutics Inc | COM | 279870109 | $3.5K | 280,000 | 0.0% |
| Macrogenics Inc(MGNX) | COM | 556099109 | $3.5K | 170,000 | 0.0% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $3.1K | 405,000 | 0.0% |
| Enanta Pharmaceuticals Inc(ENTA) | COM | 29251M106 | $3.0K | 90,000 | 0.0% |
| Strongbridge Biopharma PLC | ORD SHS | G85347105 | $2.8K | 1,160,000 | 0.0% |
| Omeros Corp(OMER) | COM | 682143102 | $2.6K | 265,300 | 0.0% |
| Clearside Biomedical Inc(CLSDUSD) | COM | 185063104 | $2.4K | 270,000 | 0.0% |
| Lion Biotechnologies Inc | COM | 53619R102 | $2.1K | 300,000 | 0.0% |
| Abeona Therapeutics Inc(ABEO1EUR) | COM | 00289Y107 | $1.9K | 400,000 | 0.0% |
| Proteostasis Therapeutics Inc | COM | 74373B109 | $1.8K | 150,000 | 0.0% |
| Imprimis Pharmaceuticals Inc | COM NEW | 45323A201 | $1.8K | 720,000 | 0.0% |
| Sage Therapeutics Inc(SG7) | COM | 78667J108 | $1.8K | 35,000 | 0.0% |
| Neuroderm LTD | ORD SHS | M74231107 | $1.7K | 115,000 | 0.0% |
| Wafergen Bio-Systems Inc | COM | 93041P506 | $1.6K | 320,000 | 0.0% |
| Corium International Inc | COM | 21887L107 | $1.5K | 380,000 | 0.0% |
| Sangamo Biosciences Inc(SGMO) | COM | 800677106 | $1.2K | 400,000 | 0.0% |
| Achaogen Inc | COM | 004449104 | $1.0K | 80,000 | 0.0% |
| Protalix Biotherapeutics Inc | COM | 74365AAB7 | $859 | 1,930,000 | 0.0% |
| Ocular Therapeutix Inc(OCUL) | COM | 67576A100 | $783 | 93,600 | 0.0% |
| Trillium Therapeutics Inc | COM NEW | 89620X506 | $622 | 110,000 | 0.0% |
| Biolinerx LTD | SPONSORED ADR | 09071M106 | $230 | 250,000 | 0.0% |
| Agile Therapeutics Inc(AGRXUSD) | COM | 00847L100 | $85 | 15,000 | 0.0% |